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ABSTRACT

DEFINING, EVALUATING, AND IMPROVING THE PROCESS OF VERIFYING PATIENT
IDENTIFIERS
SEPTEMBER 2014
JUNGHEE JO
B.Sc., PUSAN NATIONAL UNIVERSITY, KOREA
M.Sc., PUSAN NATIONAL UNIVERSITY, KOREA
M.Sc., KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY, KOREA
M.Sc., CARNEGIE MELLON UNIVERSITY
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST

Advised by: Professor Lori A. Clarke and Professor Jenna L. Marquard

Patient identification errors are a major cause of medication errors. During medication
administration, failure to identify patients correctly can lead to patients receiving incorrect
medications, perhaps resulting in adverse drug events and even death. Most medication error
studies to date have focused on reporting patient misidentiﬁcation statistics from case studies, on
classifying types of patient identiﬁcation errors, or on evaluating the impact of technology on the
patient identiﬁcation process, but few have proposed speciﬁc strategies or guidelines to decrease
patient identiﬁcation errors. This thesis aims to improve the verification of patient identifiers
(VPI) process by making three key contributions to the patient identification literature.
First, to better understand the VPI process, we extended and formalized the requirements
for VPI based on the Joint Commission’s national patient safety guidelines. We showed the
implications of these extended guidelines by applying them to artifacts typically used during
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medication administration (e.g., patient’s statements about their identity, patient’s identification
band, medication label, and medication order). We found that nurses must choose from a
considerable number of alternatives to comply with the extended guidelines. The alternatives vary
depending on whether an artifact can be trusted prior to the start of the VPI process (from 16 to 8
for manual medication administration; from 8 to 1 for barcode medication administration), or
what kind of information is encoded on the barcodes if the process involves barcode verification
technology (from 3 to 1 when the ID band is initially considered a trusted artifact; from 8 to 3
when the ID band is not initially considered a trusted artifact).
Second, we evaluated whether nurses complied with the extended VPI guidelines when
administering medications, using data from clinical simulations. Nurses’ compliance with the
extended guidelines was low under most conditions (2% - 5% for manual medication
administration; 12% - 88% for barcode medication administration).
Third, we hypothesized that compliance would improve if healthcare workers were trained
to follow a specific sequence of actions for VPI during medication administration (termed
definitive procedure-based training), rather than their current training. We evaluated nursing
students’ compliance with the extended VPI guidelines using clinical simulation, with each
student completing a simple task (administering one medication) and a complex task
(administering two medications). We found that those students who received the definitive
procedure-based training showed a significant increase in compliance on the simple task, but not
on the complex task. Among the complying students, few of them followed the specific sequence
of actions detailed in the definitive procedure-based training.
Our findings suggest further study is needed to investigate more effective approaches for
improving the VPI process, perhaps by better supporting individuals as they complete the process
(e.g., appropriately designed technology) or by improving approaches to training.
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CHAPTER 1
INTRODUCTION

Patient identification occurs during most healthcare processes involving patients. Processes
affected by patient identification errors include patient registration, treatment (e.g., blood
transfusion, medication administration, or surgery), and laboratory testing. Although the patient
identification process may appear straightforward, studies have shown it to be complex and errorprone (Henneman et al., 2010; Mannos, 2003; National Patient Safety Agency, 2004; Sevdalis et
al., 2009; Spruill et al., 2009).
Patient identification errors are one of the major causes of medication errors (Lisby et al.,
2005; Mannos, 2003; Spruill et al., 2009). According to estimates by the Institute of Medicine,
hospitalized patients experience approximately one medication error per day of their stay
(Institute of Medicine, 2006). As shown in Figure 1.1, approximately 26% - 38% of medication
errors occur during medication administration (Andersson et al., 2010; Leape et al., 1995).
Further studies have found that up to 80% of these medication administration errors were due to
patient misidentification (Lisby et al., 2005).

Figure 1.1. Proportion of medication errors attributable to patient identification errors
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During medication administration, failure to correctly identify patients can lead to patients
receiving incorrect medications, perhaps resulting in adverse drug events and even death
(Schulmeister, 2008). Moreover, patient misidentification may also harm patients who do not
receive their intended medications because their medications were erroneously given to other
patients (Hakimzada et al., 2008; Ranger et al., 2004). Most patient identification studies to date
have focused on reporting patient misidentification statistics from case studies (Henneman et al.,
2010; Henneman et al., 2012; Leape et al., 1995), on classifying types of patient identification
errors (Mannos, 2003; National Patient Safety Agency, 2004; Schulmeister, 2008), or on
evaluating the impact of technology on the patient identification process (Henneman et al., 2012;
Patterson et al., 2002; Snyder et al., 2010).
Several organizations have suggested guidelines to increase the accuracy of patient
identification, including the National Patient Safety Agency, the Joint Commission on
Accreditation of Healthcare, and the World Health Organization. In 2003 the Joint Commission
introduced “Improve the accuracy of patient identification” as the first of its National Patient
Safety Goals and has updated it annually. The Joint Commission guidelines for fulfilling this goal
are: “Use at least two patient identifiers when providing care, treatment, and services …
acceptable identifiers may be the individual’s name, an assigned identification number, telephone
number, or other person-specific identifier … the patient's room number or physical location is
not used as an identifier …” (Joint Commission, 2013).
Healthcare facilities may train their workers by using policies and/or procedures based on
their interpretations of these guidelines. Example healthcare facility guidelines are as follows:



University Health Services at the University of Massachusetts Amherst (Amherst, MA):
“Verify 2 patient identifiers 1) Patient’s Name 2) Patient’s Date of Birth. If patient has a
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commonly used name, the patient’s medical record number is the 3rd patient identifier”
(see Figure 1.2)


Baystate Medical Center (Springfield, MA): “… the two patient specific identifiers are: 1)
the patient’s stated full name (first and last) and 2) The medical record number on
his/her ID band … match two patient specific identifiers directly associated with the
individual and the same two identifiers associated with the medication, blood product,
specimen …” (Appendix A)



Beth Israel Deaconess Medical Center (Boston, MA): “... examples of patient identifiers
include: Name, Date of birth, ... the two identifiers used to verify a patient’s identity must
be matched to the same two identifiers displayed on medication packaging, automatic
medication dispensing machines … ” (Appendix B)

Figure 1.2. Sign explaining patient identification guidelines at the University of Massachusetts
Health Services

The Joint Commission guidelines, which influence healthcare facility policies and
procedures, focus on how to select patient identifiers for verification. Unfortunately, the
guidelines provide no guidance for how to select pairs of artifacts on which to match the patient
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identifiers. Here we use the term artifact to mean an entity containing at least two patient
identifiers (e.g., ID Band), and thus an entity that could be used in the verification of patient
identifiers (VPI) process. In our study, we consider patients to be artifacts and their statements
about their identities to be patient identifiers.
Selecting pairs of artifacts for VPI is especially complex when several artifacts are involved
in the process. As shown in Figure 1.3, (a), (b), and (c) seem to meet the Joint Commission
guidelines of using at least two patient identifiers, but (c) may not prevent the patient from
receiving the wrong medication if the top two artifacts pertain to one patient and the bottom two
artifacts pertain to another.

Figure 1.3. Selection of pairs of artifacts

We suspect that extending the Joint Commission guidelines to include directions on how to
select pairs of artifacts would help healthcare workers understand the VPI process better. The
extended guidelines should include directions on how to select pairs of artifacts that are
applicable to variety of healthcare processes (e.g., medication administration, blood transfusion)
and to different types of artifacts (e.g., ID bands, blood products).
As previous studies suggest, patient identification errors are especially problematic during
medication administration. We therefore examined the implications of our guidelines for artifacts
commonly used during medication administration. The Joint Commission guidelines affect the
VPI process differently depending on whether the medication administration process uses
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barcode verification technology (Barcode Medication Administration (BCMA)) or not (Manual
Medication Administration (MMA)), so we explore the implications of both.
In the remainder of this thesis, we focus on nurses, as they play a vital role in identifying
patient identification errors; however, the insights from this research should be applicable to other
types of healthcare workers performing VPI. To gain insight into how well the extended Joint
Commission guidelines are complied with, we measured current compliance by analyzing data
from clinical simulations where nurses administered medications using MMA and BCMA.
We also suspect that training healthcare workers using explicit guidelines may improve
compliance with the VPI guidelines. Thus, we designed a guideline-based training strategy for
MMA, and evaluated the impact of the training on nursing students’ compliance with the VPI
guidelines.
In summary, this thesis approaches VPI as a complex process that is currently poorly
defined and error-prone. Our research aims to achieve the following three goals:

1. Extend the Joint Commission guidelines for VPI with specific directions for selecting
pairs of artifacts. We refer to the extended guidelines as “artifact-explicit guidelines”. To
achieve this goal, we created artifact-explicit guidelines and demonstrated the
implications of these guidelines when applied to MMA and BCMA, respectively.
2. Evaluate current compliance with the artifact-explicit guidelines. To achieve this goal, we
analyzed data collected from previous clinical simulation studies where nurses
administrated medications to mock patients using MMA and BCMA (Henneman et al.,
2010; Henneman et al., 2012).
3. Design and evaluate a training strategy to improve compliance with the artifact-explicit
guidelines. To achieve this goal, we designed a guideline-based training strategy for
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nursing students, and tested the efficacy of the training via an experiment where students
conducted MMA in a simulated clinical setting.

From our research, we obtained three major findings that contribute to the patient
identification literature. First, there are a considerable number of ways to conduct the VPI process
that comply with the artifact-explicit guidelines. These alternatives vary depending on whether an
artifact can be trusted prior to the start of the VPI process (from 16 to 8 for MMA; from 8 to 1 for
BCMA), or what kind of information is encoded on the barcodes for BCMA (from 3 to 1 when
the ID band is initially considered a trusted artifact; from 8 to 3 when the ID band is not initially
considered a trusted artifact). Second, we found that under most conditions, nurses’ compliance
with the artifact-explicit guidelines was low (2% - 5% for MMA; 12% - 88% for BCMA).
Third, we found that our training strategy showed a significant increase in nursing students’
compliance with the artifact-explicit guidelines; however, very few nursing students followed the
exact steps outlined in the training.
The remainder of this thesis is organized as follows. Chapter 2 details related work by
researchers who have analyzed the prevalence and types of VPI errors, and outlines previously
proposed strategies to comply with the Joint Commission guidelines. Chapter 3 describes the
requirements for artifact-explicit guidelines and the implications of these guidelines for MMA
and BCMA. Chapter 4 details an evaluation of nurse compliance with the artifact-explicit
guidelines for MMA and BCMA. Chapter 5 describes our proposed training strategy to improve
compliance with the artifact-explicit guidelines, and our experimental evaluation of the training
for nursing students conducting MMA. Chapter 6 summarizes our observations and provides
directions for future work.
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CHAPTER 2
RELATED WORK

Most prior work related to the VPI process has reported patient misidentification statistics
from case studies, classified types of VPI errors, or evaluated the impact of technology on the
VPI process. Only a few studies have proposed specific guidelines or strategies to decrease VPI
errors. This chapter describes studies analyzing VPI errors and proposing strategies or guidelines
to decrease VPI errors.

2.1

Analysis of VPI errors
Several studies have reported VPI errors statistics identified from case studies. Valenstein

et al. (2006) and Dunn et al. (2010) measured the frequency of VPI errors detected in clinical
laboratories. Valenstein et al. conducted a survey from 127 clinical laboratories for information
about specimen misidentification, and found that overall rate of VPI errors was 55 errors per a
million of billable tests. They also estimated that more than 160,000 adverse events per year
resulted from misidentification of patients’ laboratory specimens. Dunn et al. reported that VPI
errors accounted for 182 of 253 adverse events which occurred in all of the test cycles. Henneman
et al. (2010, 2012) reported the percentage of nurses who failed to identify VPI errors during
medication administration in clinical simulations. They found that 39% of nurses in MMA and 8%
of nurses in BCMA misidentified the patient and subsequently gave the medication to the wrong
patient.
Other studies addressing the VPI process have classified types of VPI errors. Henneman et
al. (2010) used the data from a medical center’s voluntary safety reporting system for the
classification (e.g., medication events, surgical events, laboratory events). Lippi et al. (2009) and
Dunn et al. (2010) classified the types of VPI errors in laboratory diagnostics. Lippi et al.
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classified factors that potentially contribute to VPI errors related to workflow, artifacts used in the
VPI process, or the approach taken by healthcare workers performing the VPI process (e.g.,
ordering tests on the wrong patient, entering incorrect data). Dunn et al. classified the types of
VPI errors based on 132 misidentification events occurring in laboratory medicine (e.g., patient
identification bands were labeled for the wrong patient information, laboratory tests were ordered
for the wrong patient).
The impact of technology on the VPI process has also been evaluated in some studies
addressing the VPI process. Barcode verification technology has been strongly recommended to
reduce VPI errors during medication administration. Several studies suggested that the barcode
verification technology has the potential to improve patient safety by reducing medication errors
(Paoletti et al., 2007; Poon et al., 2010; Rivish et al., 2010). One study reported that the barcode
verification technology significantly reduced the number and types of medication administration
errors (Cummings et al., 2005). Despite its potential benefits, some studies have shown that the
barcode verification technology may create new kinds of errors and have unexpected impacts on
patient safety (Akowski et al., 2008; Patterson et al., 2002; McDonald, 2006). Patterson et. al.
identified five general negative side effects of BCMA implementation (Patterson et al., 2002) and
Koppel et al. identified fifteen different types of workarounds caused by a BCMA system
(Koppel et al., 2008).

2.2

Strategies to comply with the Joint Commission guidelines
Although several studies have discussed VPI errors in healthcare processes, few have

proposed specific strategies or guidelines to decrease these errors. Lane et al. (2006) propose a
hierarchical protocol for the ideal medication administration process. Their research suggests
comparing the patient’s identification (ID) band to the patient’s chart during medication
administration, but does not specify how to deal with other artifacts. To decrease incidents of

8

patient misidentification before chemotherapy administration, Spruill et al. (2009) suggest
matching two patient identifiers, the patient’s name and medical record number (MRN), between
two specific artifacts, namely the patient’s ID band and the chemotherapy product label. With
respect to the medication administration process, Paparella (2012) recommends matching any two
patient identifiers suggested by the Joint Commission across three specific artifacts: the patient’s
statements about their identity, the patient’s ID band, and the medication order. These studies,
however, appear to focus on a specific process (e.g., medication administration, chemotherapy) or
specific artifacts (e.g., patient’s ID band, patient’s chart, chemotherapy product label, medication
order).
Henneman et al. (2010) suggest a strategy that is applicable to any number of artifacts for a
set of selected processes. First, their strategy proposes using any two patient identifiers suggested
by the Joint Commission and matching those identifiers between two specific artifacts: the
patient’s ID band and the patient’s statements about their identity. Second, their strategy proposes
matching identifiers on other artifacts to either the patient’s statements or the patient’s ID band.
They do not generalize their two-step strategy, however, to healthcare processes such as
laboratory testing, which may not involve a patient wearing an ID band. Thus, it may be
important to establish general guidelines that can be universally applied to a wider range of
healthcare processes.
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CHAPTER 3
ARTIFACT-EXPLICIT GUIDELINES FOR VPI

The Joint Commission guidelines for VPI focus on how to select patient identifiers (e.g.,
name, date of birth, MRN) but not on how to select the pairs of artifacts (e.g., patient’s statements,
ID band, medication label) on which to match patient identifiers. In this thesis, we extended the
Joint Commission guidelines to include direction on selecting pairs of artifacts, evaluated nurses’
compliance with the guidelines, and designed a training strategy to improve compliance with the
guidelines. This chapter describes our approach to extending the Joint Commission VPI
guidelines, which we term “artifact-explicit guidelines.” We also outline the implications of these
artifact-explicit guidelines when applied to the manual medication administration (MMA) and
barcode medication administration (BCMA) processes.

3.1

Requirements for artifact-explicit guidelines
To make the Joint Commission guidelines for VPI more precise, we proposed artifact-

explicit guidelines to guide healthcare workers in selecting artifacts for VPI. We believe this
extension is consistent with the intent of the Joint Commission guidelines. In this and the
following chapters, we will use “Guidelines” to refer to these artifact-explicit guidelines, which
are:

Before an artifact is used, assure that at least two patient identifiers on that artifact have
been matched with the corresponding identifiers from another artifact that is considered
to be trusted.
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An artifact is considered to be trusted if it is either known to have been previously verified
(e.g., ID band on patient’s wrist) or assumed to be correct based upon direct evidence. We define
a verified artifact to be an artifact with at least two patient identifiers that have been matched with
the corresponding identifiers from another artifact that is considered to be trusted. For example, if
the ID band is considered to be trusted and the medication label has not yet been evaluated (i.e., it
is an unverified artifact), matching the patient’s name and date of birth (DOB) on the medication
label with the name and DOB on the ID band allows the healthcare worker to now consider the
medication label to be a verified, and thus trusted, artifact. The difference between verified and
trusted artifact is that verified artifacts can be considered to be trusted but the opposite is not
necessarily true because some artifacts can be immediately trusted so do not require further
verification. For example, a patient’s statements about their identity (e.g., name and DOB) are
generally assumed to be correct without verification. Prior to the start of the VPI process, there
must be at least one trusted artifact whose patient identifiers can be matched to those identifiers
from unverified artifacts.
Most healthcare processes tend to involve several unverified artifacts. To perform the VPI
process when two or more unverified artifacts are involved, a set of artifact pairs must be
identified. We introduce the term artifact pair to indicate that at least two identifiers on one
artifact of the artifact pair are to be matched to the same identifiers on the other artifact of the
artifact pair. In subsequent figures, we represent an artifact pair using a bidirectional edge
between the two artifacts. A subset of the edges representing artifact pairs should form a path
from each unverified artifact that will be used in the healthcare process to a trusted artifact. The
selection of the artifact pairs and the matching of the identifiers for those pairs do not have to
occur in any prescribed order. After these matches have been successfully conducted, the initially
unverified artifacts that occur on this path are considered verified. We therefore introduce the
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term identifying set of artifact pairs to indicate a set of artifact pairs which is required to comply
with the Guidelines:



Definition: An Identifying Set of Artifact Pairs (ISAP) is a set of artifact pairs such that,
for each artifact pair in the set, at least two of the identifiers for one of the artifacts in
that artifact pair should be matched to the corresponding identifiers on the other artifact
of that artifact pair. An ISAP must satisfy the following conditions:

o

Condition 1: A trusted artifact is included in at least one artifact pair in the set;

o

Condition 2: For each unverified artifact that will be used, there is a subset of
artifact pairs that form a path to a trusted artifact.

Figure 3.1 provides two examples of ISAPs and one example of a non-ISAP. In this figure,
the bidirectional edges between the artifacts represent the artifact pairs. Each edge is labeled with
a letter, A-F, with each dark edge indicating that the artifact pair is in the ISAP and a light edge
indicating that the artifact pair is not in the ISAP. In Figure 3.1(a), the set of artifact pairs,
{A,B,C}, satisfies both conditions and is an ISAP: a trusted artifact is included in at least one
artifact pair in the set (A, B, and C satisfy Condition 1); for each unverified artifact on the topright, bottom-left, and bottom-right, there is a subset of artifact pairs that form a path to the
trusted artifact: {C}, {A}, and {B} respectively (satisfies Condition 2). In the same way, in
Figure 3.1(b), {C,E,F} is an ISAP because a trusted artifact is included in at least one artifact pair
in the set (C satisfies Condition 1); for each unverified artifact on the top-right, bottom-left, and
bottom-right, there is a subset of artifact pairs that form a path to the trusted artifact: {C}, {F,C},
and {E,F,C} respectively (satisfies Condition 2). In Figure 3.1(c), {C,E} is not an ISAP because
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for each unverified artifact on the bottom-left and bottom-right, there is no path to the trusted
artifact (violates Condition 2).

Figure 3.1. ISAP and non-ISAP examples

The requirements to comply with the Guidelines do not impose a specific ordering of the
matching of identifiers among the artifact pairs. For example, in Figure 3.1(a), given the ISAP
{A,B,C}, the artifact pairs can be selected in any order (i.e., ABC, ACB, BAC, BCA, CAB, or
CBA) for VPI.

3.2

Implications of the artifact-explicit guidelines
To understand the implications of the Guidelines, we applied the Guidelines to a specific

set of artifacts typically used in medication administration (i.e., patient’s statements, medication
label, medication order, and ID band) and associated patient identifiers (i.e., name, DOB, and
MRN). The following assumptions underlay this thesis:



A patient’s collective statements about their identity are considered a trusted artifact.
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All other artifacts are initially considered unverified artifacts, unless explicitly stated
otherwise.



If at least two patient identifiers are determined to be correct for an artifact, all of its
identifiers are assumed to be correct.



The medication label contains patient identification information.

These assumptions may not always be correct, as addressed in Chapter 4.4. In this thesis,
we evaluated nurse compliance with the Guidelines during the medication administration process
for a patient-identified medication, meaning that the medication contains patient identification
information (e.g., medications for chemotherapy (Jacobson et al., 2009; Spruill et al., 2009)).
Labels for common medications (e.g., aspirin) often do not contain this information. While the
label on a patient identified medication includes patient identification information in a human
readable form, the barcode on the medication label does not necessarily include this information,
as the FDA’s Bar Code Label Requirements do not require patient identification information be
included in medication barcodes (FDA, 2011).
Figure 3.2 shows the typical artifacts and associated patient identifiers used in the
medication administration process. The four typical artifacts result in six artifact pairs (A-F)
potentially available for VPI. To perform the VPI process, an ISAP must be selected using a
subset of the six artifact pairs. In addition, for each artifact pair in the selected ISAP, at least two
identifiers on one artifact in the pair should be matched to the same identifiers on the other
artifact in the pair. The two identifiers are selected from a small set of alternatives: the
alternatives are restricted either to two available identifiers (i.e., name and DOB) for each of the
three artifact pairs A-C, or three available identifiers (i.e., name, DOB, and MRN) for each of the
three artifact pairs D-F. Because the identifiers are selected from a such a small set of alternatives,
we did not consider alternatives in selection of identifiers in this thesis.
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Figure 3.2. Six artifact pairs with at least two of the same types of patient identifiers

For the typical artifacts shown in Figure 3.2, where there is one trusted artifact and three
unverified artifacts, the total number of possible ISAPs1 is 38. Among these 38 possible ISAPs,
there are 16 minimal ISAPs. A minimal ISAP ensures that healthcare workers conduct at least a
minimal number of matches between artifacts to successfully perform the VPI process. For each
minimal ISAP, additional matches for VPI could be performed by including one or more extra
artifact pairs in the set.
Identifying the minimal ISAPs is a similar problem to finding a spanning tree - a minimal
set of edges that connect all vertices in a complete graph in which each pair of vertices is
connected by an edge (Kosowski et al., 2005). Figure 3.3 shows these 16 possible minimal

1 38 ∑
– , where 4 is the number of non-ISAPs composed of 3 artifacts pairs that do not satisfy either
Condition 1 or 2.
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ISAPs 2 illustrating that VPI can be accomplished in multiple ways. Each minimal ISAP is
composed of three artifact pairs that can be selected in any order. In the following two sections,
we explore several conditions (e.g., whether an artifact can be trusted prior to the start of the VPI
process) and identify the possible minimal ISAPs allowable for each.

Figure 3.3. Possible minimal ISAPs when there is one trusted artifact and three unverified
artifacts

In the following sections, we show the implications of the Guidelines for MMA and BCMA.

2 When the order of examined artifact pairs is considered, the total number of possible minimal ISAPs is 96(
) - 24), where 24 is the number of non-ISAPs composed of 3 artifact pairs that do not satisfy either Condition 1 or 2.
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3.3

MMA
In the previous section, we described the 16 possible minimal ISAPs for the situation where

there is one trusted artifact and three unverified artifacts used in MMA. In this section, we
examine several cases and identify the possible minimal ISAPs allowable for each. These include
whether the ID band is to be trusted or not, if it is not trusted whether it is to be used or ignored.
Ideally, the ID band should be verified and secured to the patient during registration prior
to conducting the medication administration process, meaning that the ID band could be
considered a trusted artifact. Studies have shown, however, that some patients’ ID bands contain
incorrect information (Dhatt et al., 2011; Sevdalis et al., 2009; Snyder et al., 2010). To show the
impact of assuming a trusted ID band on the Guidelines, we take into account two cases in our
analysis: the ID band is not initially considered a trusted artifact (i.e., it is an unverified artifact)
and the ID band is initially considered a trusted artifact.
The leftmost column of Figure 3.4 includes a description of these two cases regarding the
ID band. Note that the first case is divided into two sub-cases depending on whether the nurse
verifies and uses the ID band or ignores the ID band. We use the abbreviation ID Band Used (BU)
and ID Band Ignored (BI) for the first case and ID Band Trusted (BT) for the second case. The
third column indicates the number of trusted artifacts and unverified artifacts for each case. The
fourth column shows abbreviations for each of the 3 cases in MMA, a table including the total
number of manual matches required for VPI, one example of the possible minimal ISAPs, and a
figure depicting the example.
For each of the 3 cases, we identify all possible minimal ISAPs that satisfy the
aforementioned conditions in Chapter 3.1 and the number of manual matches required for each of
the minimal ISAPs. For example, the conditions for an ISAP in the case of MMA_BU are: a
trusted artifact (i.e., patient’s statements) is included in at least one artifact pair in the set
(satisfies Condition 1); and for each unverified artifact (i.e., medication label, medication order,
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and ID band), there is a subset of artifact pairs that form a path to the trusted artifact (satisfies
Condition 2). The total number of possible minimal ISAPs satisfying these conditions is 16, as
shown in Figure 3.3. During the VPI process, for each of the three artifact pairs in the selected
minimal ISAP, two patient identifiers on one artifact in the pair should be matched to the same
identifiers on the other artifact in the pair; thus, the total number of required manual matches is 6,
as shown in Figure 3.4. The figure depicting one example minimal ISAP {A,B,C} shows that the
artifact pairs, A, B, and C, each represented by a dark edge, are in the minimal ISAP, and D, E,
and F, each represented by a light edge, are not in the minimal ISAP. In the case of MMA_BI, the
total number of possible minimal ISAPs is 3 ({A,B}, {A,E}, and {B,E}) and the total number of
required manual matches for each of the minimal ISAPs is 4. In the case of MMA_BT, the total
number of possible minimal ISAPs is 8 ({A,B}, {A,D}, {A,E}, {B,E}, {B,F}, {D,E}, {D,F}, and
{E,F}) and the total number of required manual matches for each of the minimal ISAPs is 4.

Figure 3.4. The minimal number of manual matches and an example of an associated minimal
ISAP for the 3 cases in MMA
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3.4

BCMA
In BCMA, barcodes are placed both on the patient’s ID band and the medication label.

Before medications are given to a patient, the barcode on the patient’s ID band is scanned to
automatically match the patient identifier(s) on the ID band with those from the Electronic
Medical Record (EMR), thereby opening the patient’s medication order screen within the EMR.
Scanning the barcode on the ID band thus replaces the task of manually performing VPI between
the ID band and the medication order, but only if the ID band barcode is encoded with at least
two patient identifiers. The barcode on the medication is also scanned to match the medication
name and dose of the medication with those of the medication order in the EMR. As described in
Chapter 3.2, the label on a patient identified medication includes patient identifiers in a human
readable form, but the barcode on the label does not necessarily include patient identification
information; thus, a nurse still needs to manually performing VPI on the medication label using
human-readable patient identifiers on the medication. Therefore, healthcare workers need to be
aware of what information is encoded on the barcodes to perform a VPI process appropriate for
that design. Figure 3.5 shows six artifact pairs available for manually performing VPI (A-F) and
two barcode scans (Scan Band and Scan Med) represented by dotted edges.

Figure 3.5. Six artifact pairs and two barcode scans available for VPI in BCMA
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To show the impact of barcode design on VPI, we consider 6 barcode designs where the ID
band and medication label barcodes are encoded with zero, one, or two patient identifiers. Note
that the ID band barcode is encoded with at least one patient identifier, so we did not consider the
case in which the ID band barcode is encoded with zero patient identifiers.
To show the impact of using a trusted ID band for each barcode design, we consider two
cases in our analysis: ID Band Used (BU) and ID Band Trusted (BT). Note that scanning the
barcode on the patient’s ID band is mandatory for conducting the VPI process in BCMA, so ID
Band Ignored (BI) is not a possible case in BCMA. Therefore, we consider a total number of 12
cases in BCMA: 6 barcode designs in the case of BCMA_BU and 6 barcode designs in the case of
BCMA_BT, as shown in Figure 3.6.
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Figure 3.6. The number of barcode scans, minimal number of manual matches, and an example
of an associated minimal ISAP for the 12 cases in BCMA

For each of the 12 cases, we identify associated possible minimal ISAPs and the number of
barcode scans and manual matches required for each of the minimal ISAPs. For example, the
conditions for an ISAP in the case of BCMA BU when the ID band barcode is encoded with 1
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patient identifier and the medication label barcode is encoded with zero patient identifiers are: a
trusted artifact (patient’s statements) is included in at least one artifact pair in the set (satisfies
Condition 1); and for each unverified artifact (i.e., barcoded medication label, EMR, and
barcoded ID band), there is a subset of artifact pairs that form a path to the trusted artifact
(satisfies Condition 2). The total number of possible minimal ISAPs satisfying these conditions is
8. Figure 3.7 shows these 8 possible minimal ISAPs along with scanning the barcode on the ID
band.

Figure 3.7. Possible minimal ISAPs in the case of BCMA_BU when the ID band barcode is
encoded with 1 patient identifier and the medication label barcode is encoded with zero patient
identifiers

For each of the three artifact pairs in the selected minimal ISAP, two patient identifiers on
one artifact in the pair should be matched to the same identifiers on the other artifact in the pair,
either manually or using a barcode scan. As shown in Figure 3.6, the actions required for the VPI
process for this case is: scan the barcode on the ID band, manually match 2 patient identifiers for
each of the two artifact pairs by choosing one of 8 sets (AB, AC, AE, AF, BE, BF, CE, and CF),
and manually match 1 patient identifier for D because the other patient identifier is matched by
scanning the ID band barcode. Thus, the total number of barcode scans is 1 and the total number
of manual matches is 5. The figure depicting one example minimal ISAP {A,B,D} shows that A,
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B, and D, each represented by a dark edge, are in the minimal ISAP and C, E, and F, each
represented by a light edge, are not in the minimal ISAP. In the case of BCMA_BT when the ID
band barcode is encoded with 1 patient identifier and the medication label barcode is encoded
with zero patient identifiers, the number of associated possible minimal ISAPs is 3 ({A,D},
{D,E}, and {D,F}). The actions required for the VPI process for this case is: scan the barcode on
the ID band, manually match 2 patient identifiers for one artifact pair by choosing one of 3
artifact pairs (A, E, and F), and manually match 1 patient identifier for D because the other
patient identifier is matched by scanning the ID band barcode. Thus, the total number of barcode
scans is 1 and the total number of manual matches is 3.

3.5

Discussion
The number of possible minimal ISAPs and associated number of manual matches

described in the previous sections leads to several observations. First, the VPI process that
complies with the Guidelines can be accomplished in a considerable number of ways, which vary
depending on the assumptions one makes about the context of the process, as described in Figure
3.4 and Figure 3.6. Second, trusting the ID band reduces the number of alternatives for
conducting the process by at least 50%, regardless of whether BCMA is used or not: the number
decreases from 16 to 8 (50%) in MMA, and from 8 to 3 (62%) or 3 to 1 (67%) in BCMA. Third,
BCMA reduces the number of alternatives for conducting the process at least 50%, regardless of
whether the ID band can be trusted or not: the number decreases from 16 to 8 (50%) or 16 to 3
(81%) when the ID band is not initially considered a trusted artifact, and from 8 to 3 (62%) or 8
to 1 (87%) when the ID band is initially considered a trusted artifact. Fourth, depending on what
kind of information is encoded on the barcodes for BCMA, the number of alternatives for
conducting the process and required manual matches vary, as described in Figure 3.6. Encoding
the ID band and medication label barcodes with two patient identifiers reduces the number of
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alternatives and manual matches the most: the number of alternatives decreased from 8 to 3 (62%)
and the number of manual matches decreased from 5 to 2 (60%) when the ID band is not initially
considered a trusted artifact, and the number of alternatives decreased from 3 to 1 (67%) and the
number of manual matches decreased from 3 to 0 (100%) when the ID band is initially considered
a trusted artifact.
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CHAPTER 4
EVALUATING COMPLIANCE WITH ARTIFACT-EXPLICIT GUIDELINES

As discussed in Chapter 2.2, Henneman et al. suggested a strategy to comply with the Joint
Commission guidelines but lacked a full exploration of the way VPI could be completed (e.g.,
Henneman et al. considered only 4 out of the 16 alternatives to conduct the VPI process during
MMA), and so we were interested in how well nurses complied with our detailed Guidelines.
This chapter describes our evaluation of nurse compliance using clinical simulation data
from Henneman studies (2010, 2012). These studies were carried out at a 600 bed, urban, level 1
trauma, pediatric and tertiary referral center with an annual ED census > 100,000. The study was
approved by the hospital’s Institutional Review Board, and all nurse participants read and gave
informed consent. The following subsections describe the procedure for collecting data and
generating the sequences of nurses’ activities, and our approach for analyzing how well nurses
complied with the Guidelines.

4.1

Study procedure
Nurses administered medications in two different experiments. Twenty-eight nurses gave a

medication to each of two patients (i.e., 56 trials) without the help of barcode verification
technology (i.e., MMA) and twenty-five nurses gave a medication to one patient (i.e., 25 trials)
with the support of barcode verification technology (i.e., BCMA). The experiments used the same
four artifacts (i.e., patient’s statements, medication label, medication order, and ID band) and
associated patient identifiers (i.e., name, DOB, and MRN) typically used during in medication
administration, as described in the previous chapter (see Chapter 3.2). In both experiments, a
researcher led each nurse to a series of numbered rooms where students acting as patients were
waiting. Each patient had an ID band secured to their wrist. For each patient, the researcher gave
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the nurse a medication order and a medication, each labeled with the patient identification
information. The nurse then performed a medication administration process on each patient. All
nurses wore an eye-tracking device that included a camera for recording a video with cross hairs
showing where each nurse was looking throughout the process. In both experiments, nurses were
told that the purpose of the study was to evaluate how healthcare workers use visual cues to
perform tasks (Henneman et al., 2010); thus, they were not aware that the purpose of the study
was to evaluate the VPI process.
After completing the simulations, we reviewed the eye-tracking videos for quality. Of the
56 videos created during MMA, we discarded 12 (21%) videos because of insufficient video
quality, leaving 44 (79%) videos for our analysis. We included all 25 (100%) of the videos
created during BCMA in the analysis.
We carefully translated the videos into traces. By trace, we mean the complete sequence of
VPI-related events performed by a nurse. We defined event names based on a set of predefined
activities associated with VPI during medication administration. Given the standardized set of
event names, two researchers independently reviewed the videos and created the event sequences.
In the few cases when there was disagreement between these two researchers on an event
assignment, a third researcher reviewed the video and made the final decision on the event
assignment.

4.2

Analysis approach
In analyzing the traces, we considered that an actual match between identifiers on two

artifacts is unlikely to occur if there are too many intermediate events between the first and
second part of the match. To denote the distance between theses intermediate events, we define
Inter-Identifier Distance (Dist) to be the shortest distance (i.e., the number of intermediate events)
between the first and second part of a match between identifiers on an artifact pair within a trace.
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We assume a shorter Dist is more likely to lead to an actual match because working memory
gradually decays, becoming progressively less precise as information is retained for longer
periods of time (Cornelissen et al., 2000). In Figure 4.1 (a), the Dist of the match for name is 0
because there are no intermediate events between the first and second part of the match. The Dist
of the match for DOB is 1 because there is one intermediate event (i.e., Looked at MRN on the ID
Band) between the first and second part of the match. In our analysis, when determining whether
nurses actually performed the match or not, we considered three values of Dist: Dist = 0, Dist
1, and any Dist (i.e., Dist

infinity), to observe how compliance with the Guidelines varied

depending on how relaxed we assumed the Dist value could be. In Chapter 4.4, we address the
limitations of these three choices of Dist.

Figure 4.1. Sample shortened traces from nurses using MMA and BCMA

We also accounted for the fact that it was sometimes unclear which identifier the nurse was
fixating on during the BCMA trials, largely because of glare on the computer screen. To address
this limitation, we considered two assumptions: 1) while looking at the artifact, the nurse did not
fixate on any identifiers on the artifact (which indicates a lower bound for the true number of
identifier that the nurse fixated on) and 2) while looking at the artifact, the nurse fixated on every
identifier on the artifact (which indicates an upper bound for the true number of identifier that the
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nurse fixated on). Under the former assumption, we found that almost no nurses complied with
the Guidelines using BCMA. Hence, we considered only the results under the latter assumption in
our analysis. While using this assumption yielded the best possible performance of nurses
complying with the Guidelines, a surprisingly small percentage of nurses complied with the
Guidelines, as is addressed in the following two sections

4.3

Results
The number and percentage of traces complying with the Guidelines is shown in Figure 4.2.

The leftmost column includes a description of two cases depending on whether the ID band is
trusted or not. The first case is divided into two sub-cases depending on whether the nurse
verifies and uses the ID band or ignores the ID band. The third column indicates the number of
trusted artifacts and unverified artifacts for each case. The tables in the fourth column show the
numbers and percentages of traces complying with the Guidelines for each of the three values of
Dist.
Since the success rate for matching at least two identifiers (upper numbers in non-italics)
was often very low (e.g., 0% - 5% for MMA_BU), we wondered whether nurses matched at least
one identifier instead of the recommended two identifiers. We therefore also counted the number
of traces matching at least one identifier for each artifact pair in a selected minimal ISAP (lower
numbers in italics), although we do not recommend this practice. The number of traces complying
with the Guidelines was determined for each of the three values of Dist (Dist = 0, Dist ≤ 1, and
any Dist), as described in the previous section. For example, in the case of MMA_BU, of the 44
traces, the number of traces complying with the Guidelines by matching at least two identifiers is:
0 (0%) for Dist = 0; 1 (2%) for Dist ≤ 1; and 2 (5%) for any Dist. The number of traces
complying with the Guidelines by matching at least one identifier is: 9 (21%) for Dist = 0; 18
(41%) for Dist ≤ 1; and 25 (57%) for any Dist.
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Figure 4.2. Number and percentage (rounded to the nearest integer) of traces complying with the
Guidelines by matching at least two identifiers (upper numbers in non-italics) and by matching at
least one identifier (lower numbers in italics) in MMA.

We compared results for what we consider a realistic set of assumptions (i.e., the ID band is
not trusted, requiring its verification before being used and Dist

1) and a relaxed set of

assumptions (i.e., the ID band is trusted and any Dist). In Figure 4.2, the results under the realistic
assumptions are shown with a black background. The results under the relaxed assumptions are
shown with a gray background. Under the realistic assumptions, the number of traces complying
with the Guidelines is 1 out of 44 (2%). Under the relaxed assumptions, the number of traces
complying with the Guidelines is 11 out of 44 (25%). Reducing the requirement of using at least
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two identifiers to using at least one identifier considerably increased the percentage of nurses
complying with the Guidelines but would presumably increase the likelihood of VPI error. The
percentages increased from 2% to 41% under the realistic assumptions and from 25% to 64%
under the relaxed assumptions.
Figure 4.3 reproduces Figure 4.2 but replaces the results for MMA (i.e., the fourth column)
with the results of BCMA - numbers and percentages of traces complying with the Guidelines for
each of the 12 cases depending on what identifiers are encoded in the ID Band and medication
label (see Chapter 3.4). Note that scanning the barcode on the patient’s ID band is mandatory for
conducting the VPI process in BCMA, so ID Band Ignored (BI) is not a possible case in BCMA
and is thus excluded from this table.
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Figure 4.3. Number and percentage (rounded to the nearest integer) of traces complying with the
Guidelines by matching at least two identifiers (upper numbers in non-italics) and by matching at
least one identifier (lower numbers in italics) in BCMA.

Depending on what information the nurses may have believed to be on the barcodes, the
number of traces complying with the Guidelines ranges from 3 out of 25 (12%) to 8 out of 25
(32%) under the realistic assumptions and ranges from 14 out of 25 (56%) to 22 out of 25 (88%)
under the relaxed assumptions. Reducing the requirement of using at least two identifiers to using
at least one identifier considerably increased the percentage of nurses complying with the
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Guidelines. For example, when the ID band barcode is encoded with 1 patient identifier and the
medication label barcode is encoded with zero patient identifiers, the percentages increased from
12% to 56% under the realistic assumptions and from 56% to 72% under the relaxed assumptions.
BCMA increased compliance more than MMA. Assuming the barcodes on the ID band and
medication label were encoded with two patient identifiers, the increase in the percentages was
statistically significant (p = 0.001; Fisher exact test); however, assuming the barcode on the
medication label was encoded with no patient identifiers, the increase was not statistically
significant (p = 0.117; Fisher exact test).

4.4

Limitations
There are several limitations to our evaluation of nurse compliance with the Guidelines.

First, the clinical simulations from the Henneman studies were conducted at a single hospital
using emergency department nurses. We do not know whether the observed nurse behavior is
comparable to that exhibited by other healthcare workers in other settings. Second, the simulated
setting may not accurately reflect the actual clinical setting where there is more time pressure,
noise, and interruptions. We would expect compliance to be even lower in a clinical setting where
these pressures exist. Third, we had to discard 12 videos (21%) because of eye-tracking failures.
Fourth, because of our small sample size, this analysis does not provide conclusive evidence
about nurses’ behaviors. Fifth, we assumed a patient’s collective statements about their identity to
be correct because at least one artifact must be trusted at the start of the process, but this may not
always be true (e.g., altered level of consciousness, intellectual disability, language problem,
patient deception). Sixth, we considered two situations in our analysis depending on whether the
ID band was trusted or not. We do not know, however, whether or not nurses had been trained to
trust the ID band. Seventh, we analyzed our results considering three values of intermediate
events. If we knew more precisely the acceptable number of intermediate events between the first
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and the second part of a match, we could simplify the analysis of determining whether a nurse
performed a match or not. Finally, our analysis made the assumption that if at least two patient
identifiers were determined to be correct for an artifact, all of its identifiers were assumed to be
correct. For example, two identifiers on an artifact could be verified and then two other identifiers
on that artifact could be subsequently used to verify other artifacts. We don’t know how
frequently some, but not all, of the identifiers on an artifact are wrong. Since, this thesis did not
focus on selecting patient identifiers, errors associated with some incorrect identifiers were not
considered.

4.5

Discussion
We believe our Guidelines are consistent with the intent of the Joint Commission

guidelines and made it possible for us to determine nurse compliance for VPI. When we
evaluated whether nurses complied with the Guidelines during clinical simulations of medication
administration, we found that a small percentage of nurses complied with the Guidelines
regardless of whether they used MMA or BCMA. Note that the compliance in BCMA was
measured under the assumption that the nurse fixated on every identifier on the computer screen
when screen glare obscured our ability to identify what the nurse was actually fixating on during
the trials. Thus, the number of identifiers assumed in this analysis is an upper bound on the true
number of identifiers that the nurses actually matched; still, only 12% - 32% complied in BCMA.
Regardless of which barcode design the nurses may have believed to be applicable, few nurses
complied with the guidelines; compliance ranged from 12% assuming the barcode on the
medication label was encoded with no patient identifiers to 32% assuming the barcodes on the ID
band and medication label were encoded with two patient identifiers. One reason for such low
compliance is that the nurses did not perform the manual match(es) still required in BCMA. For
example, encoding two patient identifiers on the ID band and medication label barcodes still

34

requires one manual match for compliance. Most nurses scanned the two barcodes but did not
perform the required manual match and so did not comply with the Guidelines. Nurses’ failures to
comply with the Guidelines suggest that BCMA technology alone does not cover the VPI
process, so there is a need for further studies to improve nurses’ compliance.

Table 4.1. Summary of the percentage of traces complying with the artifact-explicit guidelines
under a realistic set of assumptions.

The use of barcodes in improving accurate patient identification has obtained considerable
attention. Several studies suggest that the barcode verification technology that supports
medication administration has the potential to improve patient safety by reducing medication
errors (Paoletti et al., 2007; Poon et al., 2010; Rivish et al., 2010). Despite this benefit, some
studies have shown that barcode verification technology may create new kinds of errors and have
unexpected impacts on patient safety (Akowski et al., 2008; Patterson et al., 2002; McDonald,
2006). Our results show that the use of barcode verification technology improved compliance
with the Guidelines (the percentages increased from 2% up to 32%). One possible interpretation
of this result is that the improvement in compliance is due to a reduction in the cognitive burden
associated with lowering the number of artifact pairs requiring manual matches.
Our findings suggest several ways of improving nurse compliance with the Guidelines that
should be studied further. One possible reason for low nurse compliance with the Guidelines
could be that nurses are not being trained adequately to fulfill the Guidelines. Nurse compliance
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might be improved by more carefully explaining the Guidelines, especially with respect to the
selection of artifacts. Another reason for low compliance might be that the large number of
alternatives allowed by the Guidelines makes the Guidelines difficult to remember. Thus, it may
be possible to improve compliance by simplifying the process, perhaps by reducing the number of
possible alternatives for VPI. For example, one way to reduce the number of alternatives for VPI,
thereby reducing cognitive burden, would be to train healthcare workers to select one trusted
artifact and use it to verify each of the other unverified artifacts that will be used.
For BCMA, compliance with the Guidelines may improve if healthcare workers are aware
of the information encoded on barcodes, as the appropriate VPI process depends on the barcode
design. Teaching healthcare workers a specific sequence of actions for VPI based on the chosen
barcode design may prevent healthcare workers from having to choose among different
alternatives. Selected strategies should also account for concerns that have been noted in other
studies, such as time pressures, nurses’ confidence in their existing practices, and the potential to
irritate patients (Paparella, 2012; Phipps et al., 2012).
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CHAPTER 5
IMPROVING COMPLIANCE WITH ARTIFACT-EXPLICIT GUIDELINES

In the study described in Chapter 4, we found that only a small percentage of nurses
complied with the artifact-explicit guidelines, whether they were verifying patient identifiers
manually or using barcode technology. In the study described in this chapter, we propose a
guideline-based training strategy to improve compliance with the artifact-explicit guidelines. We
then describe how we experimentally evaluated the proposed training method to an approach
currently used in nursing student education.

5.1

Proposed training strategy
VPI training practices are not well-documented, thus we made several assumptions with the

help of domain experts. We assume that the nurses who participated in our preliminary study
received the following types of training, both focused on selecting appropriate patient identifiers,
consistent with the emphasis of the Joint Commission guidelines:



In nursing school, they were given textbook-based procedural guidelines



In the workplace, they were given polices and/or procedures during their job orientation

We hypothesized that one reason for the low rate of nurse compliance could be that VPI
training focuses on how to select patient identifiers but not on how to select artifact pairs. Nurse
compliance might be improved if healthcare workers are trained using our proposed artifactexplicit guidelines, which include directions on the selection of artifact pairs.
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Another reason for low compliance might be that the large number of alternatives allowed
by the artifact-explicit guidelines makes the guidelines difficult to remember. Thus, it may be
possible for us to improve compliance with the guidelines if we simplify the process by reducing
the number of alternatives for VPI. One way to reduce the number of alternatives for VPI is to tell
individuals exactly which steps to complete.
In this study, we proposed a strategy that would ideally improve compliance with the
artifact-explicit guidelines by training individuals to follow an explicit sequence of actions for
VPI, specifically with respect to the selection of artifact pairs. We term this type of training
definitive procedure-based training. In the medical domain, healthcare workers use checklists, an
approach similar to that of definitive procedure-based training. Checklists are widely used to
reduce human error, thereby reducing the number of potential medical errors (Avrunin et al.,
2012; Bergeron et al., 2001; Hales and Pronovost, 2006). Studies have shown that checklists
contribute significantly to improvements in compliance with various key practices (Hall et al.,
2004; Pronovost et al., 2003; Wolff et al., 2014).
We hypothesized that after receiving definitive procedure-based training, individuals will
be better able to comply with artifact-explicit guidelines.

5.2

Definitive procedure
There are several approaches for specifying the definitive procedure to be used in the

training, though they range in complexity.
One definitive procedure might say to match a currently unverified artifact with a trusted
artifact. Thus, the first selected pair would include the trusted artifact and any unverified artifact.
The next pair could include the trusted or newly verified artifact3 and another unverified artifact,

3 The artifact was initially an unverified artifact but is now considered to be a verified artifact. This is because at least
two patient identifiers have been matched with the corresponding identifiers from another artifact that is considered to
be trusted.
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and so on. Using this definitive procedure, however, may make it difficult for healthcare workers
to keep track of the status of each artifact - whether it is trusted, newly verified, or unverified thus increasing the likelihood of error.
Another definitive procedure might say to select one trusted artifact and use it to verify all
unverified artifacts that will be used in the process. This definitive procedure is simple to follow,
since all matches are done with the initially selected trusted artifact. In this case, however, if the
trusted artifact is the patient’s statement confirming their identity, healthcare workers must
continuously question patients, which may potentially irritate them.
Our definitive procedure states that healthcare workers should use the ID band as the
trusted artifact, as it contains only patient identity information and is available for all patients.
Ideally, the ID band should be verified and secured to the patient during registration, which
would make the ID band a trusted artifact at the start of any later processes. Studies have shown,
however, that some patients’ ID bands may contain incorrect information (Dhatt et al., 2011;
Sevdalis et al., 2009; Snyder et al., 2010). Thus, this definitive procedure needs to take into
account two cases: the ID band is not initially considered a trusted artifact or the ID band is
initially considered a trusted artifact. When the ID band is not initially considered a trusted
artifact, as shown in Figure 5.1 (a), healthcare workers should first verify the ID band using a
trusted artifact (e.g., patient’s statements) and then use the trusted ID band to verify all unverified
artifacts that will be used. When the ID band is initially considered a trusted artifact, as shown in
Figure 5.1 (b), healthcare workers should use the ID band to verify all unverified artifacts that
will be used.
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(a) When the ID band is not initially

(b) When the ID band is initially

Figure 5.1. Example of the definitive procedure

5.3

Research questions and hypotheses

In this study, we answered two broad research questions:



Research question 1 (RQ1): Does definitive procedure-based training improve healthcare
workers’ compliance with the artifact-explicit guidelines more than does current training?

To address this question, we examined two sub questions. In the ‘simple’ task, participants
administered one medication to a patient. In the ‘complex’ task, participants administered two
medications to a patient. Regarding RQ1.1 and RQ1.2, we hypothesize that definitive procedurebased training will result in better compliance than does the current training (H1).

o

Research question 1.1 (RQ1.1): For the simple task, does definitive procedurebased training improve healthcare workers’ compliance with the artifact-explicit
guidelines more than does current training?
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o

Research question 1.2 (RQ1.2): For the complex task, does definitive procedurebased training improve healthcare workers’ compliance with the artifact-explicit
guidelines more than does current training?

Ideally, the effectiveness of the training should be valid regardless of the task’s complexity
on which the training is to be applied. Thus, we examined whether the definitive procedure-based
training produced consistent results across a simple (administering one medication) and a
complex (administering two medications) task.
Additionally, the effectiveness of the definitive procedure-based training should be
preserved when moving from the simple task to the complex task. That is, the smaller the
decrement, the more useful the training. Our second research question is therefore as follows:



Research question 2 (RQ2): Does definitive procedure-based training reduce the
decrement in compliance with the artifact-explicit guidelines when moving from the
simple task to the complex task more than does current training?

Regarding RQ2, we hypothesize that definitive procedure-based training will reduce the
decrement in compliance when moving from the simple task to the complex task more than does
current training (H2).

5.4

Experimental design
We conducted the experiment at the College of Nursing at the University of Massachusetts

Amherst. During the experiment, we observed nursing students (n=48) as they conduct MMA in a
simulated patient care setting. All participating nursing students were juniors and had learned
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about the concept of patient safety. For this experiment, we did not involve barcode technology
since most hospitals still manually perform VPI when administrating medications. Even when
barcode technology is used, there are still situations where VPI must be performed manually (e.g.,
barcode scanner errors). This experiment was approved by the University of Massachusetts
Amherst’s Institutional Review Board.
Participants were divided into two groups: one group was provided with current training
material; another group was provided the definitive procedure-based training material. For the
current training, a domain expert slightly modified the ‘General Drug Administration Guidelines’
obtained from a textbook 4 currently used at the College of Nursing at the University of
Massachusetts Amherst (Figure 5.2).
We created the definitive procedure-based training materials with the help of a domain
expert (Figure 5.3). The training materials serve as a guide for each step of the process,
suggesting which specific artifact pairs should be selected and which two patient identifiers
should be matched.

4 Source: Adams M.P. and Urban C. Pharmacology: Connections to Nursing Practice, 2nd edition, Prentice Hall, 2013
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Figure 5.2. Current training material for MMA
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Figure 5.3. Definitive procedure-based training material for MMA

All participants read and signed informed consent forms. Each participant was asked to
read a script and nursing report (Appendix C). The script described that the purpose of the study
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was to compare two methods for teaching medication administration; thus, the participants would
not be aware that the purpose of the study is to evaluate the VPI process. The nursing report
explained that the health condition of the patient and asked to administer medication(s) to the
patient.
The experimental session consisted of four parts, as shown in Figure 5.4. In the first part
(pre-test), all participants were asked to perform MMA given the following artifacts: a patient, an
ID band on their wrist, a medication administration record (MAR), and a medication. In the
second part (intervention), half of the participants were trained using the current training material
(control group) and the other half were trained using our proposed definitive procedure-based
training material (treatment group). In the third part (post-test with the simple task), all
participants were asked to perform MMA, and were given the same artifacts that were used in the
pre-test. In the fourth part (post-test with the complex task), all participants were asked to
perform MMA, and were given two medications instead of one medication. We gave permission
to participants to refer to the training material while they performed the process, but did not
answer questions about the training materials.

Figure 5.4. Experimental design
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During all tasks, the participants wore an eye-tracking device, and a camera on the device
recorded a video of each participant’s view. After placing and calibrating the eye-tracking device
(Appendix D), a researcher led the participant to the simulated patient room where a student
acting as a patient was waiting. Each patient had an ID band secured to their wrist. The researcher
gave the participant a clipboard with a MAR and asked the participant to pick out the medications
for the patient from the medication station (a table placing several patients’ medications) and to
administrate the picked medications to the patient. In the simple task, the participant is supposed
to administrate IV bag; during the complex task, the participant supposed to administrate both IV
bag and Tylenol bag.
As shown in Figure 5.5, we labeled all artifacts with patient identifiers in exactly the same
way. We designed the labels to look realistic yet but with the patient identifiers more spread out.
We placed the patient identifiers on different vertical and/or horizontal axes on the labels to make
it easier to distinguish which specific patient identifier the participant was looking at. The MAR,
ID band, and the medication bags were labeled with a patient’s name, gender/age, MRN, and
DOB; the medication bags were labeled with the medication name and dose along with the
patient identifiers.
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A MAR for the simple task

A MAR for the complex task

A label for the ID band, IV bag, and Tylenol bag

A label for IV bag

A label for Tylenol bag

Figure 5.5. Experiment artifacts
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5.5

Analysis approach
After completing the experiments, we reviewed the eye-tracking videos for quality. Of the

53 videos created during the experiments, we discarded 5 (9%) videos because of insufficient
video quality, leaving 48 (91%) videos for our analysis. Of the 48 videos, half of the videos
(n=24) belong to the control group associated with the current training; the other half of the
videos (n=24), to the treatment group associated with the definitive procedure-based training.
We carefully translated the videos into traces. We defined event names based on a set of
predefined activities associated with VPI during medication administration (Appendix E) and
developed guidelines for generating a trace from a video (Appendix F). Given the standardized
set of event names and the guidelines, two volunteers independently reviewed the videos and
created the event sequences. The inter-rater agreement between the two volunteers generating
traces regarding all events (n=71) was 76% (k=0.76) and the percentage agreement was 90%;
regarding only events related with compliance with the Joint Commission guidelines (n=18), the
inter-rater agreement was 72% (k=0.72) and the percentage agreement was 88% (Appendix G).
In those cases when there was disagreement between the two coders over an event
assignment, a third volunteer reviewed the video and resolved the conflict. One experienced
researcher reviewed the reconciled traces by focusing on the participants’ verbal steps (e.g., ask
patient’s name, ask patient’s DOB, and ask allergies) and made the final decision on the event
assignment. Those videos failing to synchronize between the participant’s voice and image on the
video required special attention for encoding the associated verbal steps.
The finalized traces were analyzed to evaluate whether the participants complied with the
artifact-explicit guidelines. As we did in our previous study, we analyzed the traces by
considering the acceptable number of intermediate events between the first and the second part of
a match. Figure 5.6 shows one example of such a case where the Dist of the match between the
ID Band and MAR to confirm a patient’s name is 2 because there are two intermediate events
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(i.e., Looked at DOB on ID Band and Stated DOB by Patient) between the first and second part
of the match; the Dist of the match between the ID Band and MAR to confirm a patient’s DOB is
2 because there are two intermediate events (i.e., Stated DOB by Patient and Looked at Name on
MAR) between the first and second part of the match.

Figure 5.6. An example of a shortened trace from nursing students showing matching two patient
identifiers between the ID Band and MAR

When we analyzed traces to determine compliance, we considered what we deemed a
realistic set of assumptions: the ID band is not trusted, requiring its verification before being used
and Dist

2. Studies have shown that some patients’ ID bands contain incorrect information

(Dhatt et al., 2011; Sevdalis et al., 2009; Snyder et al., 2010) and so considering the ID band not
to be trusted would be a more realistic consideration than trusting the ID band. In Chapter 5.7, we
discuss the limitations of choosing the value of the Dist.
We analyzed our data in several ways. In Figure 5.7 (a), we used the data from all
participants and measured the compliance changes from the pre-test. Figure 5.7 (b) describes the
analysis involving the data from all participants’ performance in the simple and complex tasks
(not from the pre-test) since it is unknown why some participants complied in the pre-test. Figure
5.7 (c) describes the analysis involving the data from only the participants who did not comply in
the pre-test. For those participants who did comply in the pre-test, we could not be sure that their
subsequent compliance resulted from previous experience or our training. Thus, we used data
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only for those non-complying participants’ performance in in the simple and complex tasks. In
Figure 5.7 (b) and 5.7 (c), raw compliance in the simple task and complex task is used to address
RQ 1.1 and RQ 1.2, respectively. Compliance change from the simple to the complex task is used
to address RQ2.

Figure 5.7. Three different methods of analysis

We conducted the aforementioned analyses assuming the ID Band was not trusted, but
considering both Dist

2, and a more stringent Dist

1, meaning only 0 or 1 number of

intermediate events are allowed between the first and the second part of a match. Under the more
stringent assumptions, for all three of the aforementioned analysis approaches, we found that
those students who received the definitive procedure-based training showed an increase in
compliance, but this was not statically significant.
Among these six different analyses – three analyses under realistic assumptions and another
three analyses using more stringent assumptions – we present one below, consisting of the data
and approach shown in 20(a), and assumed assuming the ID Band was not trusted and Dist
The results of the other five analyses are reported in Appendix H.
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2.

5.6

Results
Of the 24 participants given the definitive procedure-based training, the number of

participants who complied with the artifact-explicit guidelines was: 5 (20.8%) in the pre-test, 14
(58.3%) in the simple task, and 6 (25%) in the complex task.
Table 5.1 shows these results; the left table is for the current training and the other is for the
definitive procedure-based training. The first three columns of each table show the compliance
for each task. The remaining three columns show the compliance change from one task to another
task. Specifically, the fourth column indicates compliance change when each participant moved
from the pre-test to the simple task. The compliance change is classified using three values, -1, 0,
and 1; where -1 indicates compliance “got worse” implying that the participant did comply in the
pretest but not in the complex task; 0 indicates compliance “did not change” implying that the
participant did (did not) comply in the pretest and also did (did not) comply in the complex task;
1 indicates compliance “improved” implying that the participant did not comply in the pretest but
did comply in the complex task. Similarly, the fifth column indicates compliance change when
each participant moved from the pre-test to the complex task, and the sixth column indicates
compliance change when each participant moved from the simple to the complex task. Of these
results, the percentage of participants whose compliance “improved” from the pre-test to the
simple task is used to address RQ 1.1; from the pre-test to the complex task is used to address RQ
1.2; and from the simple task to the complex task is used to address RQ 2.

51

Table 5.1. Compliance results

The compliance change between the two groups of the participants is shown in Figure 5.8.
Those participants who received the definitive procedure-based training showed an increase in
compliance from the pre-test to the simple task (see Figure 5.8 (a)): 8.3% of participants who
received the current training improved compliance; 37.5% of participants who received the
definitive procedure-based training improved compliance. The increase in the percentages was
statistically significant (p=0.012; Fisher exact test). Those students who received the definitive
procedure-based training showed no change in compliance from the pre-test to the complex task
(see Figure 5.8 (b)): 8.3% of participants who received the current training improved compliance;

52

8.3% of participants who received the definitive procedure-based training improved compliance.
Those students who received the definitive procedure-based training showed an increase in
compliance when moving from the simple task to the complex task (see Figure 5.8 (c)): 25% of
participants who received the current training improved compliance; 35.7% of participants who
received the definitive procedure-based training improved compliance.

Figure 5.8. Difference in compliance between two groups

For each of the complying participants who were given the definitive procedure-based
training, we identified which ISAPs were used for VPI. This analysis is valuable for investigating
whether the participants used the ISAP advocated by the training. In the simple task, as shown in
Figure 5.9 (a), the four artifacts resulted in six artifact pairs potentially available for VPI, where
the total number of possible minimal ISAPs is 16. Among these 16, the minimal ISAP advocated
by the definitive procedure-based training is shown in Figure 5.9 (b).
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(a) 6 APs potentially available for VPI

(b) The minimal ISAP advocated by the
definitive procedure-based training

Figure 5.9. The advocated minimal ISAP in the Simple Task

Figure 5.10 shows all of the ISAPs used by participants who complied with the artifactexplicit guidelines during the simple task (n=14). The percentage of complying students who
used an ISAP recommended by the definitive procedure-based training is 28.6% (4 out of 14).

Figure 5.10. ISAPs used by students who complied in the Simple Task (n=14)

Among the four participants who used an ISAP recommended by the definitive procedurebased training (i.e., the ISAP in the green box in Figure 5.10), we examined how many of them
followed the order of matching (i.e., MAR and each of the medications  Patient’s statements
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and ID band  ID band and at least one of the medications) as well as the type of patient
identifiers recommended by the training (i.e., name and DOB). We found that 50% of the
participants (2 out of 4) followed both of them; 25% of the participants (1 out of 4) followed the
order of matching but not the type of identifiers; 25% of the participants (1 out of 4) followed
neither the order nor choice of identifiers. Figure 5.11 shows an example performed by one
participant following the recommended order of matching, but not the types of identifiers instead of name and DOB, the participant used name and MRN between the medication label and
MAR.

Figure 5.11. An example following the recommended order of matching, but not the type of the
patient identifiers in the Simple Task

Next, we investigated which artifact pairs were used for VPI for each of the participants
(n=24), regardless of compliance. As shown in Figure 5.12, for each artifact pair, we represented
the frequency of use by the thickness of the edge, e.g., 45.8% (in the current training in Figure
5.12) indicates the percentage of the participants who used an artifact pair of the patient’s
statements and ID band. In the simple task, the students who were given the definitive procedurebased training performed more matches, and thus had a higher percentage for all artifact pair
except two. For either of the training types, students tended to use the same three artifact pairs the
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most: Patient’s statements and ID band (45.5% for the current training; 87.5% for the definitive
procedure-based training), ID band and MAR (41.7% for the current training; 41.7% for the
definitive procedure-based training), MAR and medication label on the IV bag (45.8% for the
current training; 87.5% for the definitive procedure-based training).

Figure 5.12. The percentage of students who used the artifact pair in the Simple Task

In the same way, we also investigated which ISAPs and artifact pairs were used for VPI in
the complex task. As shown in Figure 5.13 (a), the five artifacts resulted in ten artifact pairs
potentially available for VPI, where the total number of possible minimal ISAPs is 125. In the
training material, as part of the VPI process, we instructed “For each medication, match patient’s
name and DOB between the MAR and the Medication Label” and then “Match patient’s name
and DOB between the ID Band and the Medication Label on at least one of the medications”.
Since the patient’s name and DOB on each medication label is already matched with the
corresponding information on the MAR, matching at least one of the medication labels with the
ID band also verifies other medication labels. Depending on which medication is selected by the
student to match with the ID band, there are two possible minimal ISAPs. Among 125 possible
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minimal ISAPs, the two minimal ISAPs advocated by the definitive procedure-based training are
shown in Figure 5.13 (b).

(a) 10 APs potentially available for VPI

(b) Two minimal ISAPs advocated by the
definitive procedure-based training

Figure 5.13. The advocated minimal ISAPs in the Complex Task

Figure 5.14 shows all of the ISAPs used by the participants who complied with the artifactexplicit guidelines during the complex task (n=6). The percentage of the complying students who
used an ISAP recommended by the definitive procedure-based training is 16.7% (1 out of 6); who
used an ISAP recommended by definitive procedure-based training along with the additional
selected artifact pairs (shown as yellow edges) is 33.3% (2 out of 6); who used an ISAP not
recommended by definitive procedure-based training is 50% (3 out of 6).
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Figure 5.14. ISAPs used by students who complied in the Complex Task (n=6)

Among the three participants who used an ISAP recommended by the definitive procedurebased training (i.e., the ISAP in the green box in Figure 5.14), or those including additional
artifact pairs (i.e., the ISAP in the blue box in Figure 5.14), we examined how many followed the
order of matching as well as the type of patient identifiers recommended by the training. We
found that none of the participants (0 out of 3) followed both the ordering and types of artifactpairs; 33.3% of the participants (1 out of 3) followed the order of matching but not the types of
identifiers; 66.6% of the participants (2 out of 3) followed neither the ordering and types of
artifact-pairs. Figure 5.15 shows an example performed by one participant following the
recommended order of matching, but not the types of identifiers - instead of name and DOB, the
participant used name and MRN between the ID band and medication label and between the
medication label and MAR.
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Figure 5.15. An example following the recommended order of matching, but not the type of the
patient identifiers in the Complex Task

Figure 5.16 shows the usage of artifact pairs in the complex task. Between the two groups,
we could not find significant differences in the percentages of the participants using any artifact
pairs. For example, in the current training, 9 participants used an artifact pair of the ID band and
MAR, but in the definitive procedure-based training, similarly 6 participants used the same pair.
For either of training, students tended to use the same three artifact pairs the most; Patient’s
statements and ID band (62.5% for the current training; 91.7% for the definitive procedure-based
training), ID band and MAR (37.5% for the current training; 25% for the definitive procedurebased training), MAR and medication label on the IV bag (41.7% for the current training; 33.3%
for the definitive procedure-based training) and on the Tylenol bag (37.5% for the current training;
37.5% for the definitive procedure-based training).
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Figure 5.16. The percentage of students who used the artifact pair in the Complex Task

We investigated whether the amount of time spent reviewing the training material had
relevance to compliance. We measured the average time spent on the training material by
complying and non-complying participants. As shown in Table 5.2, in the simple task, for either
of the training types, complying students tended to spend more time reviewing the training
materials than non-complying students - the time increased by 28% for the current training and 17%
for the definitive procedure-based training. This increase was not statistically significant,
however. In the complex task, it seems there was no relationship between compliance and the
time spent reviewing the training materials.
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Table 5.2. Time spent reviewing the training material

Next, we examined whether there were other impacts of the training on participants’
behaviors. To do this, we measured the percentage of the participants who washed their hands
and asked the patient about known allergies during the process, respectively (Appendix I). Table
5.3 shows that a few students tended to perform these two actions in the pre-test, but after both
types of training, the percentage of the participants performing these actions dramatically
increased.
Table 5.3. Other impacts of the training
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As the last analysis, we examined whether practicing nurses in the clinical simulation (see
Chapter 4 and Henemman et al., 2010, 2012) performed VPI better than nursing students during
the medication administration process. For nursing students, we used the data from the pre-test.
Since both practicing nurses and nursing students performed the same process using the same sets
of artifacts in a simulated setting, this comparison could be reasonable. As shown in Table 5.4,
nursing students tended to comply significantly more often than practicing nurses (p=0.02; Fisher
exact test).

Table 5.4. Comparing compliance of Practicing Nurses to Student Nurses

5.7

Limitations
This study has several limitations in terms of the setting, intervention, analysis, and

findings. As to the setting, the simulated clinical setting may not accurately reflect actual clinical
settings because the simulated clinical setting may involve time pressures, noises, and
interruptions different from those in actual clinical settings. The students’ schedules limited the
amount of time available for their participation in the study. This meant that they may have felt
rushed and therefore did not perform optimally. Also, this time limitation meant the length of
time between reviewing the training materials and carrying out the medication administration was
short. The students may have performed better if they were given more time to absorb the
material. In addition, because the students are aware that their clinical performance was being
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evaluated, they may have performed the process differently than they would in an actual clinical
setting.
Pertaining to the intervention, the materials we used to provide current training for VPI
may not be generalizable across nursing schools. In addition, we did not perform a preliminary
study evaluating compliance which might have exposed weaknesses in the material for the
definitive procedure-based training. If the training material had improved based on the initial
compliance results, compliance may have improved. The interval between receiving a training
intervention and performing the process may also affect compliance. Compliance in our study
may be higher than usual because the training intervention occurs immediately before the
students perform the process.
In terms of our analysis, the number of intermediate events between the first and the second
part of a match we used in this study is only an estimate based on the participants in our study and
so may not be appropriate for other participants. Also, the interpretation of the eye-tracking
videos is affected by the distance between the cross-hairs and the students’ actual eye position. To
address this limitation, we had two volunteers independently review the videos, with one
volunteer reconciling discrepancies between the initial volunteers’ traces, and one experienced
researcher reviewing the reconciled traces to make a final decision on the event assignment. The
experienced researcher knew which group the student was associated with and this may have had
an inadvertent effect on determining the final event assignment. In addition, students’ fixations
may not necessarily signify where they direct their attention. Eye-tracking videos show only
students’ fixation points but does not reveal any information about their mental processes (e.g.,
understanding). Thus, we cannot conclusively state that if a student looked at two identifiers on
two artifacts that they completed a match. This may mean our compliance levels were even lower
than those shown in the Results section.
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With regard to our findings, the result of this study may not be applicable to other
populations or settings since this study is conducted at a single university with nursing students.
Most of all, we did not evaluate whether improving compliance led to improved patient safety;
that research needs to be conducted in future work once approaches for improving compliance
have been found.

5.8

Discussion
Our analyses revealed several findings about how our training strategy may affect nursing

students’ compliance with the artifact-explicit guidelines.
With regard to RQ1, we found that those students who received the definitive procedurebased training showed a significant increase in compliance on the simple task (8.3% on the
current training; 37.5% on the definitive procedure-based training; p=0.012; Fisher exact test),
but not on the complex task (8.3% on the current training; 8.3% on the definitive procedure-based
training). The training material for the definitive procedure was developed considering general
situations and so the material should be applicable to simple and complex tasks; however, the
descriptions for the rules in the material may not be explicit enough to provide guidance for
complex tasks. This implies, perhaps, that training has to explicitly show complicated scenarios.
It also appears that spending more time reviewing the training material has no effects on
improving compliance in the complex task. Research suggests that performance on complex
processes by nurses improves with well-developed debriefing procedures (Henneman et al., 2014).
If we had performed such debriefing sessions, it might have helped to increase compliance on the
complex task as well as on the simple task.
Although those students who received the definitive procedure-based training showed a
significant increase in compliance on the simple task, we found that only a few complying
students chose the ISAP recommended by the training (including those that selected additional
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artifact pairs) - 28.6% (4 out of 14) in the simple task and 50% (3 out of 6) in the complex task.
Among these complying students, selecting the recommended ISAP (including those that selected
additional artifact pairs), half of these students (2 out of 4) followed the order of matching as well
as the types of patient identifiers recommended by the training in the simple task. None of the
complying students (0 out of 3) in the complex task followed both the order of matching and the
types of patient identifiers recommended by the training.
Regarding RQ 2, we found that of those students who received the current training, the
percentage of students who complied in the pretest but not in the complex task is 75.3%; and of
those students who received the definitive procedure-based training, the percentage of students
who complied in the pretest but not in the complex task is 64.3%. This implies that definitive
procedure-based training reduced the decrement in compliance when moving from the simple
task to the complex task more than current training did (from 75.3% to 64.3%). This decrease was
not statistically significant, however.
In both types of training, students tended to match the ID band and MAR, instead of the ID
band and medication label recommended by the definitive-based training. Of all students who
received the current training, 41.7% of students matched the ID band and MAR and 8.3%
matched the ID band and medication label; and of all students who received the definitive
procedure-based training, 41.7% matched the ID band and MAR and 25% matched the ID band
and medication label. This implies that matching the ID band and MAR may be easier or more
natural for students to select. We observed that students tended to hold the MAR during the
process and so it might be easier to refer to the information on it. Therefore, compliance may be
improved if the ISAP suggested by the training advocates matching the ID band and MAR.
We also found that more nursing students (20.8%) complied with the artifact-explicit
guidelines than practicing nurses (2%); this difference is statically significant (p=0.02; Fisher
exact test). This may be because students were less confident, i.e., they were more careful and
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performed more matches in the medication administration process while practicing nurses are
more confident and less careful in completing the process. Research suggests that experts do not
always perform better than novices, and sometimes perform worse. (Ericsson et al., 2007).
In addition, we found other impacts of the training not pertaining to the compliance with
the artifact-explicit guidelines. Both current and definitive procedure-based training resulted in
considerably increased numbers of the students who “washed their hands” and “asked the patient
about known allergies”. These actions would be quite important and can significantly influence
patient safety, and the training may help remind the students to perform such important actions supports previous evidence of the positive influence of checklists on behavior (Pronovost et al.,
2006).
Our findings suggest the necessity of investigating more effective approaches for
performing the VPI process or providing training. One possible way to improve the process is
involving the barcode technology. Since using the barcode scanning can reduce the number of
required manual matches, the healthcare workers could concentrate more on performing
necessary matches to complete the VPI process. In order to provide better training, we can design
the training based on the artifact pairs more frequently used in VPI.
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CHAPTER 6
CONCLUSION

Patient identification errors are one of the major causes of medication errors. Previous
studies have focused on reporting patient misidentification statistics from case studies, on
classifying types of patient identification errors, or on evaluating the impact of technology on the
VPI process. However, few studies have attempted to understand the VPI process by analyzing its
complexity in order to develop better guidelines or strategies for VPI. In our work, we obtained
three major findings that contribute to the patient identification literature. Based on these findings,
we provide directions for future work.

6.1

Major findings
First, there are a considerable number of ways to conduct the VPI process that comply with

our artifact-explicit guidelines. In particular, these alternatives vary depending on whether at least
one of the process artifacts can be trusted prior to the start of the VPI process (from 16 to 8 for
MMA; from 8 to 1 for BCMA). If BCMA technology is used in the process, the information
encoded on the barcode affects the number and types of alternatives available for VPI (from 3 to
1 when the ID band is initially considered a trusted artifact; from 8 to 3 when the ID band is not
initially considered a trusted artifact) (see Chapter 3).
Second, under most conditions, students’ compliance with the artifact-explicit guidelines
was low. A small percentage of students complied with the guidelines, whether performing MMA
or BCMA (2% - 5% for MMA and 12% - 88% for BCMA); whether the ID band was assumed to
be trusted or not (for MMA, 5% when the ID band is initially considered a trusted artifact and 2%
- 5% when the ID band is not initially considered a trusted artifact; for BCMA, 32% - 88% when
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the ID band is initially considered a trusted artifact and 12% - 32% when the ID band is not
initially considered a trusted artifact); and what information was assumed to be encoded in the
barcode for BCMA (12% - 88%) (see Chapter 4).
Third, our guideline-based training strategy was less effective for improving VPI
compliance than anticipated. Nursing students who received the definitive procedure-based
training showed a significant increase in compliance on a simple task involving administering one
medication, but not for a more complex task involving administering two medications.
Additionally, very few of the students who complied with the Guidelines followed the specific
steps outlined in the training (see Chapter 5).

6.2

Future work
Our findings suggest several research avenues that may improve VPI compliance. One

possible reason for low nurse compliance with the artifact-explicit guidelines could be that there
are a considerable number of alternatives for VPI, thereby increasing nurses’ cognitive burden in
choosing (perhaps unconsciously) among them. Our training suggested one alternative for VPI as
a means to reduce this cognitive burden. Although our results showed that the definitive
procedure-based training was not entirely effective, the concept of reducing the number of
alternatives may still be beneficial.
We may be able to design more effective training that reduces the cognitive burden
associated with choosing an alternative for VPI. One potential strategy would be to more
carefully select the set of artifact pairs advocated by the training. In our study, we did not perform
a preliminary experiment to determine if there are artifact pairs that may be easier or more natural
for individuals to select. We might also provide individuals with information about why some
sets of artifact pairs are acceptable, while others are not.
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In contrast to revising the VPI training for MMA, the number of manual matches could be
decreased (our training required 6) by using barcode technology. Individuals would still need
training on VPI, however, because the appropriate VPI process depends on what information is
encoded on the barcodes.
Subsequent studies should also determine if improving compliance with the artifact-explicit
guidelines reduces the number of errors that occur, especially those that reach the patient, since
that is the ultimate goal of VPI.
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APPENDIX A
BAYSTATE MEDICAL CENTER’S PATIENT IDENTIFICATION GUIDELINES

CO 2.100 PATIENT IDENTIFICATION POLICY
POLICY
To provide system-wide structure and guidance in patient identification.
PURPOSE
Establish a process for accurate patient identification, thus ensuring that procedures and
treatments are performed on the intended patient.
SCOPE
This policy applies to all Baystate Medical Center employees identifying patients who are
to receive a service or treatment. Different identifiers may be used in different settings as
long as their use is consistent within the clinical area and is specified in an area specific
policy or guideline. Where feasible the use of two distinct patient specific identifiers is
required.
PROCEDURE
A. Patient who can communicate
1. The person performing the initial identification does the following.
For the initial identification of a patient, request picture identification, if picture
identification is not available request the patient to state and spell their full name (first and
last) and their birth date. Where two persons are known to have the same name and birth
date, request the patient to state his/her social security number. Compare this information
with the medical record information. Any discrepancy noted when comparing the
information requires immediate resolution.
2. Prior to performance of a treatment or procedure, the person performing the
treatment or procedure does the following.
a) Match two patient specific identifiers directly associated with the individual and the
same two identifiers associated with the medication, blood product, specimen (such as
an attached label). In addition, the service or treatment must be matched to the
individual patient. PPID barcode technology will be used in those areas that have this
capability to properly identify the patient prior to medication administration and
phlebotomy procedures.
b) The two patient specific identifiers are: 1.) the patient’s stated full name (first and last)
and 2.) The medical record number on his/her ID band.
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c) In the outpatient setting the two patient specific identifiers are: 1.) the patient’s full
name (first and last) stated and spelled correctly and 2.) The patient’s birth date.

B. Patient who is unconscious, mentally incompetent or who lacks intellectual
capacity or who does not speak the language of the person performing the
identification.
1. Initial Identification
a) For the initial identification of the patient, request the person accompanying the patient
to identify the patient as described in section A.
b) If the patient is not accompanied, a photo ID should be requested to identify the patient’s
name.
c) If the patient is not accompanied, the following process is followed:
(1) John or Jane Does’ are given a medical record that begins with 08. When the
patient’s name is determined, the patient information is updated and added to the
hospital registration system. The J. Doe’s maintain the 08 medical record until
discharge at which time the health information department will merge the 08 with
the patient’s actual medical record.
(2) For identification of infants delivered in the LDRP and in the NICU/CCN refer
to Children’s Hospital Policy/Procedure: Identification, Security and Transport:
Newborn/Infant/Child).
(3) For the trauma patient, the two patient identifiers are: 1.) the medical record
number 099 and 2.)The trauma E number TR E 1234. When the patient is
positively identified, the account number is updated with the patient’s correct
information. An updated ID band will be printed and placed on the patient in
addition to the initial trauma ID band.
2. Prior to performance of a treatment or procedure, the person performing the
treatment or procedure must do the following:
a) Matching of two patient specific identifiers directly associated with the individual and
the same two identifiers associated with the medication, blood product, specimen (such
as a specimen label) must occur. In addition, the service or treatment must be matched
to the individual patient.
b) The two patient specific identifiers are: 1.) The patient’s first and last name 2.)The
medical record number on his/her ID band.
c) In the outpatient setting the two patient specific identifiers are: 1. The patient’s full
name (first and last name) and 2. The patient’s birth date.
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APPENDIX B
BETH ISRAEL DEACONESS MEDICAL CENTER’S PATIENT IDENTIFICATION
GUIDELINES
Beth Israel Deaconess Medical Center
BIDMC Manual
Title: Patient Identification Policy
Number: CP-21
Purpose: (1) To ensure reliable identification of each patient prior to the delivery of
medical care; (2) to match the intended medical care to each patient (3) to
outline the needed interdepartmental steps in order to provide timely
resolution of incorrect inpatient identity or medical record demographic
information.

Policy Statement
Patients (population defined below) shall be identified using at least two identifiers prior to
receiving medical care (defined below).
Active communication techniques (defined below) shall be used in the verification process
whenever possible.
The intended medical care shall be matched to each patient using the two patient
identifiers.

Policy for Implementation
A. Who
This policy applies, but is not limited, to the following inpatient and outpatient
populations:
1. All inpatients, including mothers admitted for labor and delivery,
newborns delivered at BIDMC, and newborns admitted to but not
delivered at BIDMC
2. Emergency Department patients
3. Patients receiving medications administered by clinical staff
4. Patients receiving other therapeutics such as radiation, radioisotopes,
etc.
5. Patients receiving blood products
6. Patients undergoing phlebotomy
7. Patients undergoing tissue biopsy or specimen collection
8. Patients receiving general, regional, or local anesthesia or conscious
sedation
9. Patients undergoing invasive procedures
10. Patients undergoing Radiology or other diagnostic studies
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B. When
The procedures in this policy must be performed immediately prior to:
1. Admission to the hospital or admission to the Emergency Department
2. The medical interventions listed in #3 – 10 in Section A in both inpatient
and outpatient settings
3. Application of identification wristbands
4. Handing newborns to mothers for breastfeeding or other care
5. Administration of expressed breast milk to newborns.
C. How
Two Patient Identifiers
Two patient identifiers shall be used to verify each patient’s identity. Examples of
patient identifiers include:
1. Name
2. Date of birth
3. Medical record number
4. Social security number

Active Communication Techniques
Active communication techniques shall be used to elicit the patient identifiers
whenever possible. In general, this means the avoidance of questions that can be
answered with “yes” or “no.” For example:
Do not ask, “Are you Jane Doe?”
Rather, do ask, “What is your name?”

Matching Patients and Medical Care
The two identifiers used to verify a patient’s identity must be matched to the same
two identifiers displayed on medication packaging, automatic medication
dispensing machines (e.g. Omnicell machines), blood product containers, order
sheets, test requisitions, etc.
This matching process must occur immediately prior to the provision of the
intended medical care.
Whenever possible, the patient should participate in this matching process. If the
patient is unable to participate (e.g. during a pre-procedure “time-out” when the
patient is anesthetized), clinicians conducting the matching process must still use
two patient identifiers and active communication techniques among themselves to
match the patient to the intended medical care.

D. Special Circumstances
Patients Admitted for Medical Emergency
Patients unable to communicate during a medical emergency (e.g. a trauma
patient in the Emergency Department) shall be issued temporary names and
medical record numbers. These temporary identifiers shall be used to identify
patients until their identities can be established.
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Admission of Patients Unable to Speak for Themselves
Patients unable to communicate for other reasons (e.g. adults with dementia or
degenerative diseases, newborns, etc) may be identified during the admission
process using information taken from (1) family members or personal caregivers
who know the patient well or (2) documentation from other health care facilities.
Information from police, fire, emergency medical services, or correctional facility
personnel or from picture identification cards may be used for identification
purposes according to local departmental policy.

Patients Transferred Internally Without Appropriate Identification
In the event that (1) a patient is transferred from one BIDMC unit to another, (2)
and such patient is unable to participate in the identification process (e.g. due to
sedation or critical illness), and (3) such patient does not have an identification
band appropriately secured to his or her person, then the transferring licensed
practitioner must report in person to the receiving unit to identify the patient prior
to any medical intervention.
E. Correcting Misidentified Patients
When staff identify any portion of patient identification as incorrect or duplicated in
system, they are to escalate the findings for resolution to their immediate supervisor.
Elements requiring immediate correction attention include:






Name
Date of Birth
Gender
Social Security Number
Patient Medical Record Number

1. Staff member who discovers incorrect identity information informs:
a. Manager or designee
b. Administrative Clinical Supervisor (if applicable)
2. Manager or designee verifies correct information with patient or guardian. All
elements of demographic information should be confirmed.
3. Manager or designee contacts Bed Placement (Ext 4-2219) with correct patient
identification. Bed Placement makes determination of whether change needed is
demographic change, merge or re-registration.
a. If demographic change, bed placement will immediately update
patient demographics.
4. Upon successful change of correct patient record, new Wristband is placed on
patient and new Blue Card is made available for use through Bed Placement.

If re-registration or merge needed, proceed to step 5, otherwise continue to step
12.
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5. For Merges and Re-Registrations
a. If merge is needed due to:
I. Patient misidentification
II. Duplicate medical record
III. EU critical with *previous admission
*Please Note
An update to an EU Critical record with NO previous admission is
considered a demographic change and does not require a merge. It is
not necessary to print POE orders for EU critical demographic
changes.
b. If re-registration is needed due to wrong identification of patient, Bed Placement
will inform caller that incorrect patient will be un-admitted and correct patient
medical record will be admitted. After this occurs, all care should be documented
in correctly admitted medical record.
For scenarios a and b, Bed Placement will notify the caller that a merge or readmission will be performed within 15 minutes and that all POE orders need to be
printed (see step 7).
6. If merge or re-registration of patient is needed, Bed Placement will contact Health
Information Management to perform the merge.
a. All Merge requests will be processed within 15 minutes of
Notification to Health Information Management.
7. If merge or re-registration is needed, Manager or designee ensures that all
pertinent medical information is printed and placed in correct patient’s medical
record including:
a.
b.
c.
d.

POE orders
Radiology results
Labs
New ID labels placed on all Medical Record documents. This is to be
completed to ensure accuracy and availability of orders and results
during the record merge/correction process.

All patient care will continue in corrected medical record in conjunction with
printed material from incorrect medical record until all pending orders are restored.
8. Manager or designee determines all pending orders and places page to
each corresponding department where order was placed.
a) Laboratory Services – Beeper 31503
b) Radiology – General Diagnostic Supervisor – Beeper33119
Determination/notification to additional departments to notify is on a
patient specific basis (informing specialties, consults, procedure/care
areas as necessary)

75

9. For all pending orders, inpatient unit must cancel old orders and reenter them using correct patient information.
10. Upon successful merge, new Wristband is placed on patient and new Blue Card is
made available for use through Bed Placement.
11. Bed Placement will complete a *Patient Information Registration Error
Alert* e-mail to the registration error distribution group informing them of patient
medical record issue and expected resolution.
*The email address for this distribution list is:
VitalInformationRegistrationErrorAllert@bidmc.harvard.edu.
It can also be found in outlook under “Patient Information Registration Error Alert”.

The content of the Patient Information Registration Error Alert E-Mail will include:

Content of Vital Information Registration Error Alert E-Mail
Incorrect Info
Patient Name
MRN
Fiscal # (Encounter)
Date/Time Admitted
Date/Time Discharged
Brief Description of situation:

Correct Info

(i.e. Demographic Change, Duplicate Medical Record, Merge, EU Critical
Update,)
12. Manager notifies patient of error and of resolution of the issue.
13. Manager or designee fills out Incident Report in Patient Safety Reporting
System.
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APPENDIX C
MATERIALS INVOLVED IN THE EXPERIMENT

A. Experiment script

B. Nursing report
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C. Consent form

Consent Form for Participation in a Research Study
University of Massachusetts Amherst

Researcher(s):

Study Title:

Junghee Jo (graduate student researcher), Jenna L. Marquard
(faculty sponsor), Elizabeth Henneman (faculty sponsor),
Lori A. Clarke (faculty sponsor)
Nurse decision making during routine procedures

1. What is this form?
This form is called a Consent Form. It will give you information about the study so you can make an
informed decision about participation in this research.
2. WHO IS ELIGIBLE TO PARTICIPATE?
Students from the School of Nursing at the University of Massachusetts Amherst
3. WHAT IS THE PURPOSE OF THIS STUDY?
The purpose of this study is to better understand how nursing students make decisions during routine
procedures.
4. WHERE WILL THE STUDY TAKE PLACE AND HOW LONG WILL IT LAST?
The study will take place in the University of Massachusetts Amherst School of Nursing Simulation
Laboratory. Participation in this study will take approximately 45 minutes. After you have
participated in the study, you will not be contacted regarding this study.
5. WHAT WILL I BE ASKED TO DO?
If you agree to take part in this study, you will be asked to perform routine procedures on mock
patients in a simulated setting. You will be asked to wear an eye-tracking device while performing the
procedures.
6. What are my benefits of being in this study?
You may not directly benefit from this research; however, we hope that the knowledge acquired from
this study will be useful for you in thinking about how you perform routine procedures.
7. WHAT ARE my RISKS OF being in THIS STUDY?
There are minimal risks associated with a possible breach of confidentiality of your research data.
8. How will my personal information be protected?
The following procedures will be used to protect the confidentiality of your study records. The researchers
will keep all study data in a secure location. Research records will be labeled with a code. A master key
that links names and codes will be maintained in a separate and secure location. De-identified data will be
kept to possibly use later for secondary analysis. All electronic files containing identifiable information
will be password protected. Any computer hosting such files will also have password protection to prevent
access by unauthorized users. Only the members of the research staff will have access to passwords. At the
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conclusion of the study, the researchers may publish their findings. Information will be presented in
summary format and you will not be identified in any publications or presentations.
9. WILL I RECEIVE ANY PAYMENT FOR TAKING PART IN THE STUDY?
You will receive $20 cash after participating in the study.
10. WHAT IF I HAVE QUESTIONS?
We will be happy to answer any questions you have about this study. If you have further questions about
this project or if you have a research-related problem, you may contact the student researcher, Junghee Jo
at junghee@cs.umass.edu. You may also contact the faculty sponsor, Professor Elizabeth Henneman at
Henneman@nursing.umass.edu, or Professor Jenna L. Marquard, at jlmarquard@ecs.umass.edu. If you
have any questions concerning your rights as a research subject, you may contact the University of
Massachusetts Amherst Human Research Protection Office (HRPO) at (413) 545-3428 or
humansubjects@ora.umass.edu.”
11. CAN I STOP BEING IN THE STUDY?
You do not have to be in this study if you do not want to. If you agree to be in the study, but later change
your mind, you may drop out at any time. There are no penalties or consequences of any kind if you
decide that you do not want to participate.
12. WHAT IF I AM INJURED?
The University of Massachusetts does not have a program for compensating subjects for injury or
complications related to human subjects research, but the study personnel will assist you in getting
treatment.
13. SUBJECT STATEMENT OF VOLUNTARY CONSENT
When signing this form I am agreeing to voluntarily enter this study. I have had a chance to read this
consent form, and it was explained to me in a language that I use and understand. I have had the
opportunity to ask questions and have received satisfactory answers. I understand that I can withdraw
at any time. A copy of this signed Informed Consent Form has been given to me.
________________________
Participant Signature:

____________________
Print Name:

__________
Date:

By signing below I indicate that the participant has read and, to the best of my knowledge, understands
the details contained in this document and has been given a copy.
_________________________
Signature of Person
Obtaining Consent

____________________
Print Name:
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__________
Date:

D. Guidelines of calibration for nursing students
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E. 12 reference points used for calibration
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F. Artifacts



ID Band



Medications in the simple task (4 IV bags)



Medications in the complex task (4 IV bags and 1 Tylenol bag)
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MAR in the simple task
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MAR in the complex task
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APPENDIX D
EYE TRACKER CALIBRATION PROCEDURE

Preparation materials for Eye-Tracking

1. Glasses set with cables attached

2. Data Tracking Units (DTU) with charger

3. SD card inserted into the DTU

4. ASL Laptop that comes with eye tracker software, “Mobile Eye XG” with Green USB, Black
USB, and Charger
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Calibration procedure
1. Plug Green USB into the left side of the ASL laptop.
2. Plug Black USB into the right side of the ASL laptop.
3. Plug the SD card into the DTU.
4. Plug glasses into the DTU.
5. Plug in the ASL laptop to an outlet.
6. Plug in the DTU to an outlet.
7. Insert battery into the DTU.
8. Turn on the DTU.
9. Turn on the ASL laptop.
10. Click Eye Vision XG on the ASL laptop screen.
11. Put the DTU in the pocket and have the subject wear the DTU pocket.
12. Ask the subject to sit.
13. If the subject wears glasses, ask them to remove glasses. If they cannot read the letters
without glasses, allow them to wear their glasses.
14. Place the glasses on the subject.
15. Adjust the bead in the back until the unit is tight around the subject’s head.
16. Put the calibration sheet in front of the subject.
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17. Advise the subject that once the calibration is done, he/she cannot move the glasses so make
sure he/she is comfortable at this point.
18. Ask the subject to stare at the middle point in the calibration sheet.
19. Adjust the camera (up and down) to include all reference points in the calibration sheet.
20. Adjust monocle to locate the pupil in the center of the screen.
21. Slide the camera until 3 dots are shown.
22. Adjust the knob around the camera until the 3 dots are dense and smaller.

23. Go to “Spot” and click: “Display”  “Auto-Threshold” and “Calibrate”.
24. Go to “Pupil” and click: “Display”  “Auto-Threshold”.
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25. Check if the threshold value is around 90%. Otherwise, adjust the focus knobs and monocle
until ideal conditions are met.
26. Advise them not to move their head but only their eyes during the calibration.
27. Guide the numbers for each point.
28. Go to “Scene” and click “Calibrate”.
29. Test from 1 to 9. Make sure to wait to click the reference point until the cross-hairs arrives at
the point.
30. Click “Finish” button.
31. Test the calibration results by asking the subject to stare a one specific point at a time.
32. Click “Record” to make the video file.
33. After ending, click “Stop” and turn off the Eye Vision XG software.
34. Carefully take the glasses off of the subject.
35. Switch out the batteries in the DTUs and charge the ones just used.
36. Copy the video file to an external hard drive.
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APPENDIX E
EVENT NAMES USED IN GENERATING TRACES


Verbal
o Introduced self
(E.g., my name is Kally. I will be your nurse today etc.)
o Asked patient to state full name
(E.g., what’s your full name?)
o Asked patient to state their first name
(E.g., what’s your first name?)
o Asked patient to state their last name
(E.g., what’s your last name?)
o Asked patient to spell first name
(E.g., what’s the spelling of your first name?)
o Asked patient to spell last name
(E.g., what’s the spelling of your last name?)
o Stated the patients full name
(E.g., your full name is Jane Kim, is that right?)
o Stated patient first name
(E.g., your first name is Jane, is that right?)
o Stated patient last name
(E.g., your last name is Kim, is that right?)
o Asked patient to state Age
(E.g., what’s your age?)
o Stated patient Age
(E.g., your age is 24, is that right?)
o Asked patient to state DOB
(E.g., what’s your DOB?)
o Stated patient DOB
(E.g., your DOB is 3/1/1990, is that right?)
o Asked patient to state Name and DOB
(E.g., what’s your name and DOB?)
o Stated patient Name and DOB
(E.g., your name Jane Kim and your DOB is 3/1/1990. Is that right?)
o Asked Allergies
(E.g., what’s your allergies?)
o Asked if allergies
(E.g., do you have any allergies?)
o Q A
(E.g., how is your pain? Are you all right? How is the weather today? etc.)
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Visual
- Looked at Name on ID Band
- Looked at Name on MAR
- Looked at Name on Med Label (T)
-

Looked at DOB on ID Band
Looked at DOB on MAR
Looked at DOB on Med Label (T)

-

Looked at MRN on ID Band
Looked at MRN on MAR
Looked at MRN on Med Label (T)

-

Looked at Age on ID Band
Looked at Age on MAR
Looked at Age on Med Label (T)

-

Looked at Med info on Med Label (T)

-

Looked at Cefotetan info on MAR
Looked at Acetaminophen info on MAR
Looked at Allergy info on MAR

-

Looked at Med admin guidelines

-

Looked at Name on Med Label #1 (IV)
Looked at Name on Med Label #2 (IV)
Looked at Name on Med Label #3 (IV)
Looked at Name on Med Label #4 (IV)
Looked at Name on Med Label (T)

-

Looked at DOB on Med Label #1 (IV)
Looked at DOB on Med Label #2 (IV)
Looked at DOB on Med Label #3 (IV)
Looked at DOB on Med Label #4 (IV)
Looked at DOB on Med Label (T)

-

Looked at Age on Med Label #1 (IV)
Looked at Age on Med Label #2 (IV)
Looked at Age on Med Label #3 (IV)
Looked at Age on Med Label #4 (IV)
Looked at Age on Med Label (T)

-

Looked at MRN on Med Label #1 (IV)
Looked at MRN on Med Label #2 (IV)
Looked at MRN on Med Label #3 (IV)
Looked at MRN on Med Label #4 (IV)
Looked at MRN on Med Label (T)

-

Looked at Med info on Med Label #1 (IV)
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-

Looked at Med info on Med Label #2 (IV)
Looked at Med info on Med Label #3 (IV)
Looked at Med info on Med Label #4 (IV)
Looked at Med info on Med Label (T)

-

Looked at MAR (General)
Looked at ID Band (General)
Looked at Med Label #1 (IV) (General)
Looked at Med Label #2 (IV) (General)
Looked at Med Label #3 (IV) (General)
Looked at Med Label #4 (IV) (General)
Looked at Med Label (T) (General)

Action
- Washed hands
- Picked up Med #1 (IV)
- Picked up Med #2 (IV)
- Picked up Med #3 (IV)
- Picked up Med #4 (IV)
- Picked up T
- Gave medication to patient
- Filled out or signed MAR
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APPENDIX F
GUIDELINES FOR GENERATING A TRACE FROM A VIDEO

1. Download and Install KM player (http://www.kmplayer.com/)
2. Press “F” for frame step forward, “Shift +F” for frame step backward
3. Track the location of the green cross-hairs and write the event name & time

Event name: “Looked at Allergy info on MAR”
Time: 0:05:23.92
Note:
- Use only pre-defined event names. While you are reviewing the video, if some event
names are not defined and need to be defined, please email me
- The minimum time the cross-hairs must remain on an identifier to be considered a
fixation is “120ms” which implies time for “3” consecutive frames. In other words, if
the cross-hairs did not remain on an identifier while you press the “F” key 3 times, it
is not a fixation
- The cross-hairs are sometimes not located right above the identifier, but the location
of the cross-hairs can be estimated based on the context of the video
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Example: “Looked at Age on MAR”
-

Sometimes the cross-hairs cannot be seen. The location of the eye fixation can be
estimated based on the context of the video

Example: “Looked at Name on Med Label”
-

Sometimes the synchronization between the participant’s voice and the image on the
video is faulty, but the location of the eye fixation can be estimated based on the
context of the video
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APPENDIX G
AGREEMENT RATE BETWEEN THE TWO VIDEO CODERS

A. All events (n=71)



Kappa value: 0.76 (substantial agreement)



Percentage agreement: 90%

B. Events related to compliance with Joint Commission guidelines (n=18)



Kappa value: 0.72 (substantial agreement)



Percentage agreement: 88%
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APPENDIX H
THE RESULTS OF THE OTHER ANALYSES
A. ID band is NOT trusted & Dist ≤ 2



Raw performance of all students (Figure 5.7 (b))
o Compliance results

o Difference in compliance between two groups
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Raw performance of non-compliers (Figure 5.7 (c))
o Compliance results

o Difference in compliance between two groups
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B. ID band is NOT trusted & Dist ≤ 1



Improvement from pre-test (Figure 5.7 (a))
o Compliance results

o Difference in compliance between two groups
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Raw performance of all students (Figure 5.7 (b))
o Compliance results

o Difference in compliance between two groups
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Raw performance of non-compliers (Figure 5.7 (c))
o Compliance results

o Difference in compliance between two groups
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ISAPs used by students who complied in the Simple Task (n=7)



ISAPs used by students who complied in the Complex Task (n=6)



The percentage of students who used the artifact pair in the Simple Task
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The percentage of students who used the artifact pair in the Complex Task
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APPENDIX I
RAW COMPLIANCE OF “WASH HANDS” AND “ASK THE PATIENT ABOUT
KNOWN ALLERGIES”
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